Source: Respirology - Category: Respiratory Medicine Tags: Cell and Molecular Biology Source Type: research

Related Links:

AbstractBenzodiazepines, available clinically for almost six decades, are still one of the most widely prescribed classes of medication. The proportion of the population prescribed benzodiazepines increases with age, and harms also increase with age. The prevalence of prescribing in people  >  85 years of age is as high as one in three, including in people with chronic obstructive pulmonary disease (COPD). The prevalence of COPD also increases with age. In COPD, indications cited for prescribing a benzodiazepine include anxiety, sleep disorders, or chronic breathlessness. Each of thes e symptoms is pr...
Source: Drugs and Aging - Category: Geriatrics Source Type: research
COVID-19 appears to get more dangerous with age, says one epidemiology professor. People with heart problems, diabetes, or lung issues like COPD are also at a higher risk for severe disease and death.WebMD Health News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
(Natural News) COPD, or chronic obstructive pulmonary disease, is an umbrella term referring to a group of progressive lung diseases. Among the common diseases classified under COPD are emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, only behind cancer and heart disease....
Source: - Category: Consumer Health News Source Type: news
THURSDAY, Feb. 27, 2020 -- Daily integrated care conferences (ICCs) are associated with shorter length of stay for patients admitted with chronic obstructive pulmonary disease (COPD) exacerbations at a community hospital, according to a study...
Source: - Pharma News - Category: Pharmaceuticals Source Type: news
Authors: Kuluöztürk M, Deveci F Abstract Aim: To determine of the prognostic value of Glasgow Prognostic Score (GPS) in acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) requiring hospitalization.Methods: Hospital electronic database of 129 patients with AECOPD was retrospectively searched and CRP levels, complete blood count, arterial blood gas (ABG) values and pulmonary function test (PFT) parameters of patients were recorded. Hospital mortality and need for ICU transfer were determined as adverse outcomes from files of cases.Results: 106 of 129 patients were male (82.2%) and rest of ...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
Chronic Obstructive Pulmonary Disease (COPD) will become the 3rd leading cause of death worldwide in 2020 and is currently the 3rd leading cause of hospital readmissions in the US. In October 2014, the Centers for Medicare and Medicaid Services (CMS) introduced penalties followed by bundle payments for care improvement initiates in patients hospitalized with an acute exacerbation of COPD (AECOPD). Fragmented care across settings cause readmissions for COPD. A patient-tailored case management initiative mitigated 30-day hospital readmissions at Sub-Acute Rehabilitation (SAR) centers.
Source: Journal of the American Medical Directors Association - Category: Health Management Authors: Source Type: research
Even patients with mild COPD exacerbations can benefit from antibiotics and systemic corticosteroids, a systematic review and meta-analysis suggests.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Pulmonary Medicine News Source Type: news
Conclusions: We observed no gender differences in the rate of exacerbations of COPD in a prospective longitudinal study. Further studies are needed to confirm these findings in the general COPD population. PMID: 32098456 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Tags: Korean J Intern Med Source Type: research
Chronic obstructive pulmonary disease (COPD) is a leading cause of death with a considerable part of the population dying from cardiovascular diseases. High-sensitivity troponin I (hs-TnI) might help to better identify COPD patients at high risk of mortality. We aimed to study the predictive value of hs-TnI for all-cause mortality beyond established COPD assessments, and after consideration of relevant cardiovascular risk factors and prevalent cardiovascular diseases, in a broad population with stable COPD. Circulating hs-TnI concentrations together with a wide range of respiratory and cardiovascular markers were evaluated...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: COPD and smoking Original Articles: COPD Source Type: research
COPD is a leading cause of death in the world. COPD represents the pulmonary component of multimorbidity, often with cardiovascular disease (CVD) as the most prevalent, and possibly the most clinically relevant [1]. Indeed, cardiovascular diseases affect quality of life and healthcare costs, and are a major cause of death in COPD [2, 3]. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) initiative recognises CVD as the most important disease coexisting with COPD and suggests it should be routinely looked for, suggesting the use of a CVD risk calculator [4].
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Editorials Source Type: research
More News: Biology | Chronic Obstructive Pulmonary | Molecular Biology